Michael Koontz

Professional Education

Fellowship: Stanford University - Hematology and Oncology (2012) CA

Residency: Stanford University Hospital -Internal Medicine Residency Training Program (2010) CA

Board Certification: Internal Medicine, American Board of Genetic Counseling (2010)

Medical Education: UC Irvine School of Medicine (2007) CA

Risk of therapy-related secondary leukemia in Hodgkin lymphoma: the Stanford University experience over three generations of clinical trials.
Koontz, M. Z., Horning, S. J., Balise, R., Greenberg, P. L., Rosenberg, S. A., & Advani, R. H. (2013). Risk of therapy-related secondary leukemia in Hodgkin lymphoma: the Stanford University experience over three generations of clinical trials. Journal of clinical oncology , 31(5), 592-598.

Neoadjuvant Imatinib for Borderline Resectable GIST
Koontz, M. Z., Visser, B. M., & Kunz, P. L. (2012). Neoadjuvant Imatinib for Borderline Resectable GIST. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 10(12), 1477-1482.